JP2022505183A5 - - Google Patents

Info

Publication number
JP2022505183A5
JP2022505183A5 JP2021521129A JP2021521129A JP2022505183A5 JP 2022505183 A5 JP2022505183 A5 JP 2022505183A5 JP 2021521129 A JP2021521129 A JP 2021521129A JP 2021521129 A JP2021521129 A JP 2021521129A JP 2022505183 A5 JP2022505183 A5 JP 2022505183A5
Authority
JP
Japan
Prior art keywords
combination according
pharmaceutically acceptable
antiviral agent
pyrrolo
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021521129A
Other languages
English (en)
Japanese (ja)
Other versions
JP7577652B2 (ja
JP2022505183A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/056632 external-priority patent/WO2020081751A1/en
Publication of JP2022505183A publication Critical patent/JP2022505183A/ja
Publication of JP2022505183A5 publication Critical patent/JP2022505183A5/ja
Application granted granted Critical
Publication of JP7577652B2 publication Critical patent/JP7577652B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021521129A 2018-10-17 2019-10-17 インフルエンザウイルス複製の阻害剤の組み合わせ Active JP7577652B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862746884P 2018-10-17 2018-10-17
US62/746,884 2018-10-17
PCT/US2019/056632 WO2020081751A1 (en) 2018-10-17 2019-10-17 Combinations of inhibitors of influenza virus replication

Publications (3)

Publication Number Publication Date
JP2022505183A JP2022505183A (ja) 2022-01-14
JP2022505183A5 true JP2022505183A5 (cg-RX-API-DMAC7.html) 2022-10-21
JP7577652B2 JP7577652B2 (ja) 2024-11-05

Family

ID=68503202

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021521129A Active JP7577652B2 (ja) 2018-10-17 2019-10-17 インフルエンザウイルス複製の阻害剤の組み合わせ

Country Status (17)

Country Link
US (1) US12233066B2 (cg-RX-API-DMAC7.html)
EP (1) EP3866778B1 (cg-RX-API-DMAC7.html)
JP (1) JP7577652B2 (cg-RX-API-DMAC7.html)
KR (1) KR102890706B1 (cg-RX-API-DMAC7.html)
CN (1) CN112969457B (cg-RX-API-DMAC7.html)
AU (1) AU2019361038B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021007275A2 (cg-RX-API-DMAC7.html)
CA (1) CA3115823A1 (cg-RX-API-DMAC7.html)
DK (1) DK3866778T3 (cg-RX-API-DMAC7.html)
ES (1) ES2939148T3 (cg-RX-API-DMAC7.html)
FI (1) FI3866778T3 (cg-RX-API-DMAC7.html)
IL (1) IL282018B2 (cg-RX-API-DMAC7.html)
MX (1) MX2021004215A (cg-RX-API-DMAC7.html)
PL (1) PL3866778T3 (cg-RX-API-DMAC7.html)
PT (1) PT3866778T (cg-RX-API-DMAC7.html)
TW (1) TWI829785B (cg-RX-API-DMAC7.html)
WO (1) WO2020081751A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230158020A1 (en) * 2020-05-23 2023-05-25 Alexandre Vasilievich Ivaschenko Method for treating RNA viral infections, including COVID-19 (SARS-CoV-2)
WO2022074630A1 (en) * 2020-10-09 2022-04-14 Auxilla Pharmaceuticals And Research Llp Liquid oral suspension of favipiravir
CN113413365B (zh) * 2021-07-30 2022-11-22 合肥医工医药股份有限公司 一种稳定的法维拉韦口服溶液制剂及其制备方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093709A (en) 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4180646A (en) 1975-01-28 1979-12-25 Alza Corporation Novel orthoester polymers and orthocarbonate polymers
US4131648A (en) 1975-01-28 1978-12-26 Alza Corporation Structured orthoester and orthocarbonate drug delivery devices
US4079038A (en) 1976-03-05 1978-03-14 Alza Corporation Poly(carbonates)
CY1308A (en) 1979-12-06 1985-12-06 Glaxo Group Ltd Device for dispensing medicaments
US4304767A (en) 1980-05-15 1981-12-08 Sri International Polymers of di- (and higher functionality) ketene acetals and polyols
US4353656A (en) 1980-10-14 1982-10-12 Xerox Corporation Moving coil, multiple energy print hammer system including a closed loop servo
EP0069715B1 (en) 1981-07-08 1986-11-05 Aktiebolaget Draco Powder inhalator
GB2169265B (en) 1982-10-08 1987-08-12 Glaxo Group Ltd Pack for medicament
DK172541B1 (da) 1982-10-08 1998-12-07 Glaxo Group Ltd Apparat til administrering af medikamenter til patienter og en medikamentpakning til brug i apparatet
US4778054A (en) 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
US4501729A (en) 1982-12-13 1985-02-26 Research Corporation Aerosolized amiloride treatment of retained pulmonary secretions
US4753788A (en) 1985-01-31 1988-06-28 Vestar Research Inc. Method for preparing small vesicles using microemulsification
AU591152B2 (en) 1985-07-30 1989-11-30 Glaxo Group Limited Devices for administering medicaments to patients
US4946931A (en) 1989-06-14 1990-08-07 Pharmaceutical Delivery Systems, Inc. Polymers containing carboxy-ortho ester and ortho ester linkages
AU6909091A (en) 1989-12-05 1991-06-26 Ramsey Foundation Neurologic agents for nasal administration to the brain
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US5968543A (en) 1996-01-05 1999-10-19 Advanced Polymer Systems, Inc. Polymers with controlled physical state and bioerodibility
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
CA2379909C (en) 1999-08-06 2011-01-04 Board Of Regents, The University Of Texas System Drug releasing biodegradable fiber implant
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US7252840B1 (en) 1999-08-25 2007-08-07 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles
US6632666B2 (en) 2000-01-14 2003-10-14 Biolife Solutions, Inc. Normothermic, hypothermic and cryopreservation maintenance and storage of cells, tissues and organs in gel-based media
US6613355B2 (en) 2000-05-11 2003-09-02 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
WO2002013897A2 (en) 2000-08-14 2002-02-21 Advanced Inhalation Research, Inc. Inhalation device and method
CA2433335C (en) 2000-12-29 2010-04-20 Advanced Inhalation Research, Inc. Particles for inhalation having sustained release properties
US6766799B2 (en) 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
US6848197B2 (en) 2001-04-18 2005-02-01 Advanced Inhalation Research, Inc. Control of process humidity to produce large, porous particles
US6524606B1 (en) 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
CA2465675C (en) 2001-11-20 2008-06-10 Advanced Inhalation Research, Inc. Improved particulate compositions for pulmonary delivery
US7008644B2 (en) 2002-03-20 2006-03-07 Advanced Inhalation Research, Inc. Method and apparatus for producing dry particles
WO2005023335A2 (en) 2003-09-05 2005-03-17 Kurve Technology, Inc. Integrated nebulizer and particle dispersing chamber for delivery of medicament
HK1254961A1 (en) 2015-12-15 2019-08-02 Shionogi & Co., Ltd. Medicine for treating influenza characterized by comprising combination of cap-dependent endonuclease inhibitor with anti-influenza drug
WO2018127096A1 (en) 2017-01-05 2018-07-12 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof
US10927118B2 (en) 2017-03-02 2021-02-23 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof
CA3059449A1 (en) * 2017-04-24 2018-11-01 Cocrystal Pharma, Inc. Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication

Similar Documents

Publication Publication Date Title
HRP20191957T1 (hr) Policiklični-karbamoilpiridonski spojevi i njihova farmaceutska upotreba
RU2420284C2 (ru) Антагонист ccr5 для усиления иммуновосстановительной терапии и лечения оппортунистической инфекции у пациентов с вич
JP2013543896A5 (cg-RX-API-DMAC7.html)
JP2015534562A5 (cg-RX-API-DMAC7.html)
JP2018188483A5 (cg-RX-API-DMAC7.html)
HRP20231018T1 (hr) Terapeutski spojevi korisni za profilaktičko ili terapijsko liječenje hiv virusne infekcije
WO2008010953A3 (en) Pyridinone diketo acids: inhibitors of hiv replication in combination therapy
HRP20211543T1 (hr) Derivati kinazolina koji se koriste za liječenje hiv-a
JP2015505565A5 (cg-RX-API-DMAC7.html)
JP2014521735A5 (cg-RX-API-DMAC7.html)
JP2015038149A5 (cg-RX-API-DMAC7.html)
EA038122B9 (ru) Ингибитор поверхностного антигена вируса гепатита b
JP2016508134A5 (cg-RX-API-DMAC7.html)
JP2012532874A5 (cg-RX-API-DMAC7.html)
JP2017528503A5 (cg-RX-API-DMAC7.html)
FI3936130T3 (fi) Valbenatsiinin annostusohjelma hyperkineettisten liikehäiriöiden hoitoon
JP2017528507A5 (cg-RX-API-DMAC7.html)
JP2018168191A5 (cg-RX-API-DMAC7.html)
FI3866778T3 (fi) Influenssa viruksen replikaation estäjien yhdistelmät
RU2019100037A (ru) Способ лечения рассеянного склероза с использованием ингибитора lsd1
HRP20211749T1 (hr) Pentanske kiseline supstituirane pirolo-[2-3,b]pirimidin-piridinima za liječenje virusnih infekcija influencom
MX2021014774A (es) Formulaciones de liberacion modificada y usos de las mismas.
HRP20241716T1 (hr) Postupci liječenja promjena u ponašanju
EP4066839A4 (en) PROPHYLACTIC AND THERAPEUTIC MEDICINAL PRODUCT FOR HIV INFECTIOUS DISEASES, CHARACTERIZED BY CONTAINING THE COMBINATION OF INTEGRAS INHIBITORS AND ANTI-HIV AGENTS
JP2021073257A5 (cg-RX-API-DMAC7.html)